Skip links and keyboard navigation

Guide for pharmacists dispensing medicinal cannabis

A patient or their medical practitioner may approach your pharmacy to assist with dispensing an approved medicinal cannabis product. Products may include both registered and unregistered medicines.

Only stock of medicinal cannabis for a named patient can be held in a pharmacy.

Guidance and regulations

The Medicines and Poisons (Medicines) Regulation 2021 describes the requirements for dispensing, recording, packaging, labelling and reporting associated with schedule 4 and schedule 8 medicines (including medicinal cannabis products).

The dispenser must:


Importation and export of medicinal cannabis products is tightly controlled. The Office of Drug Control provides information on how to access these products.

Departmental Standard – Secure storage of Schedule 8 medicines

Medicinal cannabis products, particularly those containing tetrahydrocannabinol (THC), have a high diversion value, and must have comprehensive security controls in place to manage this risk.

The Departmental Standard – Secure storage of S8 medicines outlines the requirements for storing Schedule 8 medicines, including schedule 8 medicinal cannabis products. If the medicinal cannabis is a schedule 8 medicine, it must be stored in a way that complies with the Departmental Standard – Secure storage of S8 medicines (PDF 269 kB).

Your legal obligations

The dispenser must:

  • adhere to all conditions as detailed in any TGA import licence or permit, if they are the importing party
  • comply with any conditions imposed on a TGA approval relating to the medicinal cannabis product(s) being used
  • only dispense medicinal cannabis in accordance with a prescription
  • comply with the Guidelines for Dispensing of Medicines published by the Pharmacy Board of Australia
  • comply with all reporting and recording requirements, as set down by the Medicines and Poisons (Medicines) Regulation 2021
  • ensure any excess or unused stock is disposed of and destroyed in line with the requirements under the Medicines and Poisons (Medicines) Regulation 2021
  • report any adverse events, adverse reactions, serious adverse reactions and unexpected reactions to the prescribing medical practitioner.

Under the Medicines and Poisons (Medicines) Regulation 2021, Community pharmacies and dispensing medical practitioners that dispense S8 medicinal cannabis are required to submit these dispensing records to QScript electronically via a Prescription Exchange Service (PES), along with all other dispensing records for monitored medicines prescriptions.

Visit Monitored medicines reporting requirements for further information.

Monitored medicines unit


Last updated: 28 September 2021